reviewTop 1% cited
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Atherosclerosis · 2015 · Vol. 239(2) · pp. 483–495
Marja‐Riitta Taskinen✉(Helsinki University Hospital)Jan Borén✉(University of Gothenburg)
Diabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disordersCancer, Lipids, and MetabolismDyslipidemiaPathophysiologyMedicineInternal medicineDiabetes mellitusPostprandialType 2 diabetesEndocrinologyTriglycerideLipoprotein
MeSH terms
AnimalsHypolipidemic AgentsBlood GlucoseCardiovascular DiseasesCholesterolDiabetes Mellitus, Type 2HumansIntestinal MucosaIntestinesLipoproteinsLiverRisk FactorsTriglyceridesBiomarkersPrevalence
Funding
- Fondation Leducq
- Hjärt-Lungfonden
- Vetenskapsrådet
- Novo Nordisk Fonden
Citations
431
FWCI
29.50
field-weighted impact
References
264
Percentile
100%
vs. same field & year
Citations per year
Cited by
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Atherosclerosis · 2016 · 1,581 citations
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
European Heart Journal · 2016 · 3,169 citations
The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
International Journal of Molecular Sciences · 2020 · 1,096 citations
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Atherosclerosis · 2019 · 4,829 citations
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
European Heart Journal · 2019 · 8,581 citations
References
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Journal of Clinical Investigation · 2005 · 3,421 citations
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Diabetes Care · 2001 · 4,771 citations
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Nature Genetics · 2008 · 3,326 citations
Diabetic dyslipidaemia: from basic research to clinical practice*
Diabetologia · 2003 · 868 citations
Overproduction of large VLDL particles is driven by increased liver fat content in man
Diabetologia · 2006 · 683 citations
Pathophysiology of Human Visceral Obesity: An Update
Physiological Reviews · 2013 · 2,670 citations
The interaction of hepatic lipid and glucose metabolism in liver diseases
Journal of Hepatology · 2011 · 979 citations
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Journal of Hepatology · 2010 · 1,055 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.